|1.||Wang, Zhiwu: 2 articles (07/2015 - 11/2013)|
|2.||Yan, Guozheng: 2 articles (07/2015 - 11/2013)|
|3.||Gu, Ning: 2 articles (11/2014 - 12/2006)|
|4.||Huang, Junxing: 2 articles (01/2014 - 06/2013)|
|5.||Lin, Mei: 2 articles (01/2014 - 06/2013)|
|6.||Shokrollahi, H: 2 articles (07/2013 - 01/2013)|
|7.||Zhang, Dongsheng: 2 articles (06/2013 - 12/2006)|
|8.||Zainal, Zulkarnain: 2 articles (01/2013 - 01/2013)|
|9.||Rasedee, Abdullah: 2 articles (01/2013 - 01/2013)|
|10.||Flaifel, Moayad Husein: 2 articles (01/2013 - 01/2013)|
04/01/1989 - "Lesion-to-liver contrast, expressed as the difference between the tumor and liver signal-to-noise, improved after ferrite administration in both sequences from -1 to 20 and from 7 to 15 for the 820/30, 60 sequence and from 9 to 34 and 15 to 21 for the 2200/22, 70 sequence. "
01/01/2013 - "The long-term objective of the present study was to determine the ability of NiZn ferrite nanoparticles to kill cancer cells. "
10/01/1987 - "In this study, a rodent model of cancer metastasized to the spleen was used to evaluate the potential of superparamagnetic ferrite particles as a tissue-specific reticuloendothelial contrast agent. "
11/01/2014 - "High-performance PEGylated Mn-Zn ferrite nanocrystals as a passive-targeted agent for magnetically induced cancer theranostics."
01/01/2014 - "Mn-Zn ferrite MFH, which has a targeted positioning function that only the temperature of tumor tissue with magnetic nanoparticles can rise, while normal tissue without magnetic nanoparticles is not subject to thermal damage, is a promising therapy for cancer. "
|2.||Liver Neoplasms (Liver Cancer)
12/01/1986 - "MR contrast agents (such as gadolinium-DTPA and reticuloendothelial-system-specific, superparamagnetic ferrite-iron-oxide particles) offer further promise for enhanced sensitivity for liver-cancer detection. "
01/01/2013 - "In this study, in vitro cytotoxicity of nickel zinc (NiZn) ferrite nanoparticles against human colon cancer HT29, breast cancer MCF7, and liver cancer HepG2 cells was examined. "
03/01/2015 - "These ferrite nanoparticles are compared by means of their magnetic properties, induction heating and cell viability studies for its application in magnetic fluid hyperthermia. "
11/07/2014 - "Bacterially synthesized ferrite nanoparticles for magnetic hyperthermia applications."
01/01/2014 - "We introduce briefly the composition and properties of magnetic fluid, the concept of MFH, and features of Mn-Zn ferrite magnetic nanoparticles for MFH such as thermal bystander effect, universality, high specific absorption rate, the targeting effect of small size, uniformity of hyperthermia temperature, and automatic temperature control and constant temperature effect. "
08/01/2013 - "In this work, the AC magnetically-induced heating characteristics of various viscous nanofluids with either soft ferrite (Fe3O4) or hard ferrite (CoFe2O4) superparamagnetic nanoparticles (SPNPs) were investigated to empirically and physically interpret the contribution of "Néel relaxation loss power, P(Néel relaxation loss)," or "Brown relaxation loss power, P(Brown relaxation loss)," to the total AC heat generation of intracellular hyperthermia or in-vivo hyperthermia. "
04/01/2007 - "Comparative evaluation of heating ability and biocompatibility of different ferrite-based magnetic fluids for hyperthermia application."
|4.||Ovarian Neoplasms (Ovarian Cancer)
01/01/2014 - "Accumulation and biological effects of cobalt ferrite nanoparticles in human pancreatic and ovarian cancer cells."
01/01/2014 - "The aim of this study was to synthesize superparamagnetic cobalt ferrite nanoparticles (Co-SPIONs), and to investigate their uptake, toxicity and effects on cancer stem-like properties in human pancreatic cancer cell line MiaPaCa2 and human ovarian cancer cell line A2780. "
08/06/2008 - "Magnetic cobalt spinel ferrite nanoparticles coated with biocompatible polygalacturonic acid were functionalized with ligands specific for targeting expressed EphA2 receptors on ovarian cancer cells. "
12/01/1987 - "We conclude that clinical studies are warranted to determine the value of ferrite enhanced MR as a technique for the enhanced detection of focal hepatic lymphoma."
12/01/1987 - "Ferrite-enhanced MR imaging of hepatic lymphoma: an experimental study in rats."
02/01/1988 - "Similar experiments with animal models of micronodular lymphoma also demonstrated that ferrite-enhanced MR imaging can distinguish micronodular lymphoma from normal spleen. "
02/01/1988 - "Ferrite, a new magnetic resonance (MR) contrast agent, was evaluated in the detection and diagnosis of splenic lymphoma. "
02/01/1988 - "Splenic lymphoma: ferrite-enhanced MR imaging in rats."
|1.||ferric oxide (iron oxide)
|2.||Gadolinium DTPA (Magnevist)
|8.||Reactive Oxygen Species (Oxygen Radicals)
|10.||Glutathione (Reduced Glutathione)
|2.||Induced Hyperthermia (Thermotherapy)
|3.||Drug Therapy (Chemotherapy)
|4.||Photochemotherapy (Photodynamic Therapy)